Reply to the letters to the editor regarding the sequential ART-score

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Internal Medicine III, AKH and Medical University of Vienna, Austria.
² Division of Gastroenterology and Hepatology, Department of Internal Medicine III, AKH and Medical University of Vienna, Austria. Electronic address: markus.peck@meduniwien.ac.at.

Free article

Comment

Florian Hucke et al. J Hepatol. 2014 Jul.

Free article

. 2014 Jul;61(1):177-8.

doi: 10.1016/j.jhep.2014.03.015. Epub 2014 Mar 18.

¹ Division of Gastroenterology and Hepatology, Department of Internal Medicine III, AKH and Medical University of Vienna, Austria.
² Division of Gastroenterology and Hepatology, Department of Internal Medicine III, AKH and Medical University of Vienna, Austria. Electronic address: markus.peck@meduniwien.ac.at.

No abstract available

Comment on

The ART-strategy: sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE.
Hucke F, Sieghart W, Pinter M, Graziadei I, Vogel W, Müller C, Heinzl H, Waneck F, Trauner M, Peck-Radosavljevic M. Hucke F, et al. J Hepatol. 2014 Jan;60(1):118-26. doi: 10.1016/j.jhep.2013.08.022. Epub 2013 Sep 3. J Hepatol. 2014. PMID: 24012941
The ART strategy: sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE.
Yousuf F, Cross TJ, Palmer D. Yousuf F, et al. J Hepatol. 2014 Jul;61(1):175. doi: 10.1016/j.jhep.2014.02.032. Epub 2014 Mar 18. J Hepatol. 2014. PMID: 24657396 No abstract available.
ART score for retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma: is it really applicable?
Wu J, Bai W, Han G, Fan D. Wu J, et al. J Hepatol. 2014 Jul;61(1):176-7. doi: 10.1016/j.jhep.2014.02.033. Epub 2014 Mar 18. J Hepatol. 2014. PMID: 24657402 No abstract available.